Enhanced apoptosis of squamous cell carcinoma cells by interleukin-2- activated cytotoxic lymphocytes combined with radiation and anticancer drugs

European Journal of Cancer

Volumn 36, Issue 15, 2000, Pages 2007-2017

  Yamamoto, T ^a   Yoneda, K ^a   Ueta, E ^a   Doi, S ^a   Osaki, T ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Apoptosis; Caspase; Fas; Granzyme B; LAK cells; Reactive oxygen intermediates; Squamous cell carcinoma cells

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; CASPASE INHIBITOR; CESIUM 137; CISPLATIN; FAS LIGAND; FLUOROURACIL; GRANZYME B; INTERLEUKIN 2; MONOCLONAL ANTIBODY; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL DEATH; CYTOTOXIC T LYMPHOCYTE; GAMMA IRRADIATION; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 0033800401     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00244-6     Document Type: Article

References (49)

1. W.H. Miller Jr. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer Cancer 83 1998 1471 1482
2. M.J. Staunton E.F. Gaffney Apoptosis. Basic concepts and potential significance in human cancer Arch. Pathol. Lab. Med. 122 1998 310 319
3. M.E. Huang Y.C. Ye S.R. Chen Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia Blood 72 1988 567 572
4. L. Wuarin M.A. Verity N. Sidell Effect of interferon-gamma and its interaction with retinoic acid on human neuroblastoma differentiation Int. J. Cancer 48 1991 136 141
5. S.M. Lippman R. Lotan U. Schleuniger Retinoid-interferon therapy of solid tumors Int. J. Cancer 70 1997 481 483
6. 3 in a human salivary acinar cell line Cancer Res. 49 1989 5435 5442
7. M. Sato K. Harada H. Yoshida Induction of differentiation and apoptosis and LeY antigen expression by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone) in a human salivary cancer cell line Acta. Histochem. Cytochem. 27 1994 591 599
8. T. Yamamoto K. Yoneda E. Ueta Y. Tatemoto T. Osaki Combination adoptive immunotherapy with chemoradiotherapy in oral carcinomas Int. J. Clin. Oncol. 1 1996 150 156
9. K. Yoneda T. Yamamoto E. Ueta T. Osaki Induction of cyclin-dependent kinase inhibitor p21 in vesnarinone-induced differentiation of squamous cell carcinoma cells Cancer Lett. 133 1998 35 45
10. K. Yoneda T. Yamamoto T. Osaki p53- and p21-independent apoptosis of squamous cell carcinoma cells induced by 5-fluorouracil and radiation Oral. Oncol. 34 1998 529 537
11. T. Lesuffleur A. Kornowski C. Luccinoic Adaptation of 5-fluorouracil of the heterogenous human colon tumor cell line HT-29 results in the selection of cells committed to differentiation Int. J. Cancer 49 1991 721 730
12. E. Ueta T. Osaki T. Yamamoto K. Yoneda Induction of differentiation in maxillary adenoid cystic carcinomas by adoptive immunotherapy in combination with chemoradiotherapy Eur. J. Cancer 34 1998 105 111
13. J.G.R. Boesen-de Cock A.D. Tepper E. de Vries W.J. van Blitterswijk J. Borst Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and γ-radiation downstream from caspase-8 activation J. Biol. Chem. 274 1999 14255 14261
14. C. Bowen S. Spiegel E.P. Gelmann Radiation-induced apoptosis mediated by retinoblastoma protein Cancer Res. 58 1998 3275 3328
15. J.W. Heusel R.L. Wesselschmidt S. Shresta J.H. Russell T.J. Ley Cytotoxic lymphocytes require granzyme B for the rapid induction on DNA fragmentation and apoptosis in allogeneic target cells Cell 76 1994 977 987
16. R.K. Lee J. Spielman D.Y. Zhao K.J. Olsen E.R. Podack Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells J. Immunol. 157 1996 1919 1925
17. P. Frost C.P. Ng A. Belldegrun B. Bonavida Immunosesitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas–Fas–ligand pathway of cytotoxicity Cell. Immunol. 180 1997 70 83
18. A. Sarin E.K. Haddad P.A. Henkart Caspase dependence of target cell damage induced by cytotoxic lymphocytes J. Immunol. 161 1998 2810 2816
19. F. Andrade S. Roy D. Nicholson N. Thornberry A. Rosen L. Casciola-Rosen Granzyme B directly and efficiently cleaves several downstream caspase substrates implications for CTL-induced apoptosis Immunity 8 1998 451 460
20. A.J. Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
21. T.G. Cotter J.M. Glynn F. Echeverri D.R. Green The induction of apoptosis by chemotherapeutic agents occurs in all phases of the cell cycle Anticancer Res. 12 1992 773 780
22. 2 to M transition implications for gene therapy Cancer Res. 57 1997 818 823
23. D.W. Nicolson N.A. Thornberry Caspases killer proteases Trends Biol. Sci. 22 1997 299 306
24. G.M. Cohen Caspases the executioners of apoptosis Biochem. J. 326 1997 1 16
25. M. Los S. Wesselborg K. Schulze-Osthoff The role of caspases in development, immunity, and apoptotic signal transduction lessons from knockout mice Immunity 10 1999 629 639
26. D.R. Green Apoptotic pathways the roads to ruin Cell 94 1998 695 698
27. K. Schulze-Osthoff D. Ferrari M. Los S. Wesselborg M.E. Peter Apoptosis signaling by death receptors Eur. J. Biochem. 254 1998 439 459
28. C. Scaffidi S. Fulda A. Srinivasan Two CD95(Apo-1/Fas) signaling pathways EMBO J. 17 1998 1675 1687
29. S. Nagata Apoptosis by death factor Cell 88 1997 355 365
30. G. Kroemer N. Zamzami S.A. Susin Mitochondrial control of apoptosis Immunol. Today 18 1997 44 51
31. B. Mignotte J.-L. Vayssiere Mitochondria and apoptosis Eur. J. Biochem. 252 1998 1 15
32. S. Simizu M. Takada K. Umezawa M. Imoto Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs J. Biol. Chem. 273 1998 26900 26907
33. E. Ueta K. Yoneda T. Yamamoto T. Osaki Manganase superoxide dismutase negatively regulates the induction of apoptosis by 5-fluorouracil, peplomycin and γ-rays in squamous cell carcinoma cells Jpn. J. Cancer Res. 90 1999 555 564
34. K. Ikeda K. Kajiwara E. Tanabe Involvement of hydrogen peroxide and hydroxyl radical in chemically induced apoptosis of HL-60 cells Biochem. Pharmacol. 57 1999 1361 1365
35. J.G.R. Boesen-de Cock A.D. Tepper E. de Vries W.J. van Blitterswijk J. Borst Common regulation of apoptosis signaling induced by CD95 and the DNA-damaging stimuli etoposide and γ-radiation downstream from caspase-8 activation J. Biol. Chem. 274 1999 14255 14261
36. S. Strand W.J. Hofmann H. Hug Lymphocyte apoptosis induced by CD95 (Apo-1/Fas) ligand-expressing tumor cells a mechanism of immune evasion? Nature Med. 2 1996 1361 1366
37. M. Hahne D. Rimoldi M. Schroter Melanoma cell expression of Fas (Apo-1/CD95) ligand implications for tumor immune escape Science 274 1996 1363 1366
38. C. Gratas Y. Tohma C. Barnas P. Taniere P. Hainaut H. Ohgaki Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer Cancer Res. 58 1998 2057 2062
39. M. Irmler M. Thome M. Hahne Inhibition of death receptor signals by cellular FLIP Nature 388 1997 190 195
40. T. Kataoka M. Schröter M. Hahne FLIP prevents apoptosis induced by death receptors but not by perforine/granzyme B, chemotherapeutic drugs, and gamma irradiation J. Immunol. 161 1998 3936 3942
41. S.J. Martin D.M. Finucane G.P. Amarante-Mendes G.A. O'Brien D.R. Green Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity J. Biol. Chem. 271 1996 28753 28756
42. D.M. Vanags M.I. Porn-Ares S. Coppola D.H. Burgess S. Orrenius Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis J. Biol. Chem. 271 1996 31075 31085
43. X. Luo I. Budihardjo H. Zou C. Slaughter X. Wang Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors Cell 94 1998 481 490
44. H. Li H. Zhu C.-J. Xu J. Yuan Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis Cell 84 1998 491 501
45. A. Gross X.-M. Yin K. Wang Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-X3L prevents this release but not tumor necrosis factor-R1/Fas death J. Biol. Chem. 274 1999 1156 1163
46. Z. Han K. Bhalla P. Pantazis E.A. Hendrickson J.H. Wyche Cif (cytochrome c efflux-inducing factor) activity is required by Bcl-2 and caspases and correlates with the activation of Bid Mol. Cell. Biol. 19 1999 1381 1389
47. T.M. Buttke P.A. Sandstrom Oxidative stress as a mediator or apoptosis Immunol. Today 15 1994 7 10
48. A. Cossarizza C. Franceschi D. Monti Protective effect of N-acetylcysteine in tumor necrosis factor-α-induced apoptosis in U937 cells the role of mitochondria Exp. Cell. Res. 220 1995 232 240
49. K. Banki E. Hutter N.J. Gonchoroff A. Perl Elevation of mitochondrial transmembrane potential and reactive oxygen intermediate levels are early events and occur independently from activation of caspases in Fas signaling J. Immunol. 162 1999 1466 1479